Background The risk of cardiovascular disease is increased among persons with human
immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in …

Background Cardiovascular disease (CVD) is more frequent among people with HIV (PWH)
and may relate to traditional and nontraditional factors, including inflammation and immune …

HIV infection is associated with increased cardiovascular disease (CVD), and increased
rates of myocardial infarction and stroke have been observed in HIV-infected individuals …

Importance Cardiovascular disease (CVD) is increased in people with HIV (PWH) and is
characterized by premature noncalcified coronary plaque. In the Randomized Trial to …

Abstract Background People with HIV (PWH) have increased cardiovascular events,
inflammation, and high-risk coronary atherosclerosis. Statin therapy has been shown to …

Background People living with HIV-1 infection are at greater risk for cardiovascular disease
than seronegative adults. Treatment of dyslipidaemia with statins has been challenging in …

HIV-infected patients have a greater prevalence of dyslipidemia, earlier incidence and
progression of atherosclerosis, and a nearly twofold increased risk for myocardial infarction …

Background Aim of this review is to focus the attention on people living with HIV infection at
risk of developing a cardiovascular event. What is or what would be the most suitable …

Background: Antiretroviral therapy improved the survival of patients with human
immunodeficiency virus (HIV) infection. With increased life expectancy, HIV-infected patients …

Aims With the success of antiretroviral therapy (ART), non-human immunodeficiency virus
(HIV)-related comorbidities like cardiovascular diseases (CVDs) are of increasing concern …